Subacute sclerosing panencephalitis in a tertiary care centre in post measles vaccination era.
This study was conducted to observe the impact of measles vaccination on the epidemiology of subacute sclerosing panencephalitis (SSPE) in the post measles vaccination era. This is a retrospective study from a tertiary care hospital, covering a ten year period starting a decade after the introduction of the national measles immunization programme in India. We analyzed 458 serologically confirmed SSPE cases. These patients had a high cerebrospinal fluid: serum anti-measles antibody ratio. The male to female ratio in the present study was 4.4:1. The mean age at onset of SSPE was 13.3 years, showing an increase in mean age at onset of SSPE. Clinical and other demographic details, available from 72 in-patients, are discussed in this report. Of these, a history of measles could be elicited in 34 cases. Mean latent period between measles infection and onset of SSPE was 7.8 years. Six patients gave a history of measles vaccination. A sizable percentage (15.5 %) of the patients was > or = 18 years old and considered to have adult onset SSPE. The incidence of SSPE continues to be high and this report highlights the need for further strengthening routine measles immunization coverage.
Department of Microbiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.
Malik
M
Sonia
Dar
D
Lalit
Broor
B
Shobha
Gulati
G
Sheffali
Salhotra
S
Amandeep
Kalra
K
Veena
Behari
B
Madhuri
D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood / Q000134:cerebrospinal fluid; D002648:Child; D005260:Female; D006761:Hospitals; D006801:Humans; D007194:India / Q000453:epidemiology; D008297:Male; D008458:Measles Vaccine / Q000008:administration & dosage* / Q000276:immunology; D012189:Retrospective Studies; D013344:Subacute Sclerosing Panencephalitis / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control*
D000914:Antibodies, Viral; D008458:Measles Vaccine